MPM BioImpact LLC
Related Filers (15)
- Oncology Impact Fund (Cayman) Management L.P. (55)
- UBS Oncology Impact Fund L.P. (55)
- GADICKE ANSBERT (35)
- MPM Oncology Impact Management GP LLC (32)
- iTeos Therapeutics, Inc. (20)
- Harpoon Therapeutics, Inc. (15)
- Cullinan Oncology, Inc. (10)
- TCR2 THERAPEUTICS INC. (3)
- SUNESIS PHARMACEUTICALS INC (2)
- Oncorus, Inc. (2)
- Werewolf Therapeutics, Inc. (2)
- MPM ONCOLOGY INNOVATIONS FUND LP (2)
- MPM Oncology Innovations Fund GP LLC (2)
- Reunion Neuroscience Inc. (2)
- Spring Bank Pharmaceuticals, Inc. (1)
- Show More ...
Other (19)
13F-HR
Tuesday, 2/13/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/12/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/11/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/13/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/11/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/13/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 5/13/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Wednesday, 2/24/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 11/19/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/13/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/12/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/13/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (57)
SC 13D/A
Tuesday, 8/1/2023
Reunion Neuroscience Inc.: Major Shareholders
SC 13D
Monday, 6/12/2023
Reunion Neuroscience Inc.: Major Shareholders
4
Monday, 6/5/2023
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/6/2022
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/7/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/2/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/30/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/24/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 10/18/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/14/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/12/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/5/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/30/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/27/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/16/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/16/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/13/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/13/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/8/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/8/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/2/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/31/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/25/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/12/2021
Cullinan Oncology, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/2/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/27/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/24/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/20/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/17/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/12/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/6/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/6/2021
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/4/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 4/29/2021
Werewolf Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/29/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/22/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/20/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/15/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/13/2021
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/13/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/9/2021
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3/A
Thursday, 1/14/2021
Cullinan Management, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 1/14/2021
Cullinan Management, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2020
Oncorus, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/1/2020
Oncorus, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 7/30/2020
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
iTeos Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 2/21/2019
TCR2 THERAPEUTICS INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2019
Harpoon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/13/2019
TCR2 THERAPEUTICS INC.: Initial statement of beneficial ownership of securities
3
Thursday, 2/7/2019
Harpoon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 2/6/2018
Spring Bank Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 11/6/2017
SUNESIS PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/31/2017
SUNESIS PHARMACEUTICALS INC: Initial statement of beneficial ownership of securities